Karen L. MacNaul

Statistics

Publications

Citations

H-Index

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Pennsylvania

New York Botanical Garden

Karen L. MacNaul is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, molecular pharmacology, and medicinal chemistry.

Publications per year

1988–2005

Publications

27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells

Xuan Fu, John G. Menke, Yu‐Li Chen et al. · Journal of Biological Chemistry · 2001 · 575 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression.

Karen L. MacNaul, Nicole Chartrain, Michael W. Lark et al. · Journal of Biological Chemistry · 1990 · 404 citations · Full text

Medicine, Immunology, Pathology +16

Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator

Joel P. Berger, Ann Petro, Karen L. MacNaul et al. · Molecular Endocrinology · 2003 · 321 citations · Full text

Medicine, Endocrinology, Pharmacology +10

Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice

John Ventre, Thomas W. Doebber, Margaret Wu et al. · Diabetes · 1997 · 277 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase

Ouliana Ziouzenkova, Stéphane Perrey, Liana Asatryan et al. · Proceedings of the National Academy of Sciences · 2003 · 251 citations

Life Sciences, Biochemistry, Pharmacology +17

1–5 of 38